Le Lézard
Classified in: Health
Subjects: CHI, AVO, CPG

Children's Mental Health Ontario Calls on Political Parties to Take the #KidsCantWait Pledge


CMHO is calling on party leaders and candidates to make Ontario the top province for children and youth to
access mental health supports

TORONTO, April 5, 2022 /CNW/ - Ahead of the provincial election, Children's Mental Health Ontario (CMHO) has launched the next phase of its #KidsCantWait campaign, calling on Ontario party leaders and candidates to sign the pledge to make Ontario the top jurisdiction in Canada to access child and youth mental health supports.

"Before the pandemic began, half of Ontario's children and youth were at risk for mental health issues. Sadly, the number of young people struggling with their mental health has only been increasing over the past two years," says Mary Kloosterman, Interim CEO of CMHO. "We're calling on all Ontario political leaders to sign the pledge to make Ontario the top jurisdiction in Canada for children and youth to access mental health supports."

The #KidsCantWait Pledge has four pillars that all Ontario parties can adopt if they form government to make Ontario the top jurisdiction in Canada for children and their families to access mental health supports and services:

  1. Invest $300M over the next 5 years into child and youth mental health supports and services
  2. Cut wait times for mental health services to 30 days
  3. Build more capacity in the community so kids don't end up in emergency rooms
  4. Develop a highly qualified and sustainable workforce of children's mental health professionals

"Some kids are currently waiting up to two and a half years to see a mental health professional. That means they're more likely to experience a crisis and more emergency room visits occur as a result," continued Kloosterman. "Even when kids can get faster access to a mental health professional, there's no consistency and stability in the resources and professionals they see. Our kids can't wait any longer?they need our political leaders to take action."

As part of the new phase of the campaign, CMHO is launching a new website, cmho.org/kidscantwait, which Ontarians can use to send a letter to their local candidates asking them to sign the pledge to make Ontario the number one jurisdiction in Canada for access to mental health supports for children and youth. The campaign will also see a series of videos launched on social media over the provincial campaign period encouraging the party leaders and all of their candidates to sign the pledge and take action when they are in office.

SOURCE Children''s Mental Health Ontario


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: